We are live on ! Find out more
GCM

Geneva Capital Management Portfolio holdings

AUM $4.71B
1-Year Est. Return 6.32%
This Fund
S&P 500
This Quarter Est. Return
+32.58%
1 Year Est. Return
+6.32%
3 Year Est. Return
+44.91%
5 Year Est. Return
+59.73%
10 Year Est. Return
–
AUM
$4.62B
AUM Growth
+$1.1B
Cap. Flow
+$70.8M
Cap. Flow %
1.53%
Top 10 Hldgs %
22.6%
Holding
123
New
3
Increased
67
Reduced
50
Closed
3

Top Buys

1
WDFC icon
WD-40
WDFC
+$18.9M
2
AXON
Axon Enterprise
AXON
+$17.8M
3
ESE icon
ESCO Technologies
ESE
+$12M
4
PLMR icon
Palomar
PLMR
+$11.6M
5
BCPC
Balchem Corp
BCPC
+$10.5M

Top Sells

1
PAYC icon
Paycom
PAYC
+$31.2M
2
MASI
Masimo
MASI
+$25M
3
LGND icon
Ligand Pharmaceuticals
LGND
+$17.8M
4
SXT icon
Sensient Technologies
SXT
+$15.3M
5
MCHP icon
Microchip Technology
MCHP
+$8.38M

Sector Composition

1 Technology 31.5%
2 Industrials 21.87%
3 Healthcare 19.11%
4 Consumer Discretionary 8.67%
5 Financials 6.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MASI
1
DELISTED
Masimo
MASI
$120M 2.59%
525,280
-114,034
-18% -$25M
KNSL icon
2
Kinsale Capital Group
KNSL
$7.82B
$119M 2.57%
764,778
+20,782
+3% +$2.77M
TYL icon
3
Tyler Technologies
TYL
$13.1B
$116M 2.52%
335,849
-20,263
-6% -$6.8M
FICO icon
4
Fair Isaac
FICO
$28.9B
$109M 2.37%
261,835
+8,393
+3% +$3.06M
EXPO icon
5
Exponent
EXPO
$3.06B
$102M 2.21%
1,259,502
+37,664
+3% +$2.71M
BL icon
6
BlackLine
BL
$1.77B
$102M 2.2%
1,227,084
+55,293
+5% +$3.69M
TECH icon
7
Bio-Techne
TECH
$11.2B
$101M 2.19%
1,530,048
+41,996
+3% +$2.51M
IPHI
8
DELISTED
INPHI CORPORATION
IPHI
$95.9M 2.08%
816,440
+37,076
+5% +$3.9M
FOXF icon
9
Fox Factory Holding Corp
FOXF
$795M
$92.4M 2%
1,118,854
+31,149
+3% +$1.94M
TREX icon
10
Trex
TREX
$4.66B
$86.5M 1.87%
1,330,654
+37,854
+3% +$2.02M
STAA icon
11
STAAR Surgical
STAA
$1.3B
$81.1M 1.76%
1,318,530
+36,728
+3% +$1.5M
ENV
12
DELISTED
ENVESTNET, INC.
ENV
$78.3M 1.7%
1,065,290
+152,565
+17% +$9.97M
ALRM icon
13
Alarm.com
ALRM
$2.64B
$75.6M 1.64%
1,167,029
+38,776
+3% +$1.95M
OLLI icon
14
Ollie's Bargain Outlet
OLLI
$4.08B
$75.4M 1.63%
771,989
+26,174
+4% +$2.01M
MPWR icon
15
Monolithic Power Systems
MPWR
$64.8B
$74.7M 1.62%
315,086
+9,670
+3% +$1.96M
LHCG
16
DELISTED
LHC Group LLC
LHCG
$74.3M 1.61%
426,124
+48,042
+13% +$7.05M
BFAM icon
17
Bright Horizons
BFAM
$4.02B
$70.4M 1.52%
600,769
-31,605
-5% -$3.61M
DSGX icon
18
Descartes Systems
DSGX
$6.4B
$69.1M 1.5%
1,306,182
+36,230
+3% +$1.61M
HQY icon
19
HealthEquity
HQY
$8.09B
$66.1M 1.43%
1,126,890
+17,652
+2% +$976K
CSGP icon
20
CoStar Group
CSGP
$12.2B
$63.1M 1.36%
887,220
-20,740
-2% -$1.34M
NEOG icon
21
Neogen
NEOG
$2.22B
$63M 1.36%
1,623,658
+43,192
+3% +$1.46M
BCPC
22
Balchem Corp
BCPC
$5.24B
$62.3M 1.35%
656,387
+112,312
+21% +$10.5M
OMCL icon
23
Omnicell
OMCL
$2.1B
$61M 1.32%
863,405
+22,856
+3% +$1.56M
RBC icon
24
RBC Bearings
RBC
$18.4B
$60.7M 1.31%
452,849
+14,663
+3% +$1.87M
TRHC
25
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$58.2M 1.26%
1,064,267
+124,752
+13% +$7.14M
1
2 3 4 5

Similar funds

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $4.69B AUM 24.1% 1-Year Est. Return
SCB
Saudi Central Bank Riyadh, Saudi Arabia $4.72B AUM 29.46% 1-Year Est. Return
RS
Robeco Schweiz Zurich, Switzerland $4.73B AUM 58.9% 1-Year Est. Return

Geneva Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Geneva Capital Management held 123 positions worth $4.62B, up 31% from $3.52B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q2 2020: portfolio turnover was 4.9%. Geneva Capital Management opened 3 new positions and exited 3, leaving the 123-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Industrials and Healthcare.

  • Geneva Capital Management's largest Q2 2020 buy was Axon Enterprise: 220,073 shares worth $21.6M.
  • Geneva Capital Management added most to WD-40 in Q2 2020, an estimated $18.9M increase.
  • Geneva Capital Management's biggest Q2 2020 reduction was Paycom, cutting an estimated $31.2M.
  • Geneva Capital Management fully exited Ligand Pharmaceuticals in Q2 2020, selling an estimated $17.8M.
  • Geneva Capital Management's ten largest holdings make up 23% of its $4.62B portfolio in Q2 2020.
  • Geneva Capital Management opened 3 new positions and closed 3 in Q2 2020.
  • Geneva Capital Management's portfolio value rose 31% quarter-over-quarter to $4.62B.

Based on Geneva Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.